In SLE patients:↑ CD57+ B cells (also in RRMS)Following Belimumab:↓ naive B cells↓ DN mB cells↓ ABCs, CD11c+, CD21-, CD27 low. This evidence concerns the gene B3GAT1 and systemic lupus erythematosus.